{"title":"Zinc(II) coordination compound with N′-(pyridin-2-ylmethylene)nicotinohydrazide: Synthesis, crystal structure, computational and cytotoxicity studies","authors":"Suman Adhikari , Sourav Nath , Sevgi Kansız , Nabajyoti Balidya , Anirban Kumar Paul , Necmi Dege , Onur Sahin , Ghodrat Mahmoudi , Akalesh Kumar Verma , Damir A. Safin","doi":"10.1016/j.jinorgbio.2024.112598","DOIUrl":null,"url":null,"abstract":"<div><p>In this work, we report on the synthesis of a novel zinc(II) coordination compound [ZnL<sub>2</sub>] (<strong>1</strong>), which was readily obtained from the reaction of Zn(OAc)·2H<sub>2</sub>O and <em>N′</em>-(pyridin-2-ylmethylene)nicotinohydrazide (<strong>HL</strong>) in methanol. Recrystallization of <strong>1</strong> from dimethylformamide under ambient conditions allowed to produce yellow block-like crystals of <strong>1</strong>·H<sub>2</sub>O. Complex <strong>1</strong>·H<sub>2</sub>O was characterized by FT-IR and <sup>1</sup>H NMR spectroscopy, while its optical properties were studied by UV–vis and spectrofluorimetry in methanol. The crystal structure of the title complex was revealed by single crystal X-ray diffraction and further explored in detail by the Hirshfeld surface analysis. Theoretical investigations based on the DFT calculations have also been applied to show the electronic properties of complex <strong>1</strong>. The antitumor activities of the parent ligand <strong>HL</strong> and complex <strong>1</strong> were studied using Dalton's lymphoma malignant cancer model. Both compounds were found to induce concentration-dependent cytotoxicity and apoptotic cell death, leading to a decrease in cell viability, body weight, and tumor volume in mice with the superior activity of complex <strong>1</strong> over <strong>HL</strong>. Mice treated with complex <strong>1</strong> demonstrated an increase in life span with a survival period of 23 days. Finally, using a molecular docking approach, we have probed complex <strong>1</strong> to inhibit the recombinant mouse tumor-necrosis factor alpha (mTNF).</p></div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0162013424001211","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0
Abstract
In this work, we report on the synthesis of a novel zinc(II) coordination compound [ZnL2] (1), which was readily obtained from the reaction of Zn(OAc)·2H2O and N′-(pyridin-2-ylmethylene)nicotinohydrazide (HL) in methanol. Recrystallization of 1 from dimethylformamide under ambient conditions allowed to produce yellow block-like crystals of 1·H2O. Complex 1·H2O was characterized by FT-IR and 1H NMR spectroscopy, while its optical properties were studied by UV–vis and spectrofluorimetry in methanol. The crystal structure of the title complex was revealed by single crystal X-ray diffraction and further explored in detail by the Hirshfeld surface analysis. Theoretical investigations based on the DFT calculations have also been applied to show the electronic properties of complex 1. The antitumor activities of the parent ligand HL and complex 1 were studied using Dalton's lymphoma malignant cancer model. Both compounds were found to induce concentration-dependent cytotoxicity and apoptotic cell death, leading to a decrease in cell viability, body weight, and tumor volume in mice with the superior activity of complex 1 over HL. Mice treated with complex 1 demonstrated an increase in life span with a survival period of 23 days. Finally, using a molecular docking approach, we have probed complex 1 to inhibit the recombinant mouse tumor-necrosis factor alpha (mTNF).